Researchers at Washington University School of Medicine in St. Louis have developed a novel compound that effectively clears bacterial infections in mice, including those that can result in rare but potentially fatal “flesh-eating” illnesses.
A cancer care startup is making a new bet with payers and providers: only pay if it works
A cancer care navigation startup has raised $95 million from prominent tech investors to help payers and providers spend less on cancer patients while improving